Galectin Therapeutics shares owned by Tower Research Capital
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Galectin Therapeutics by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $25k | 6.0k | 4.16 |
| 2025-06-30 | $10k | 4.8k | 2.11 |
| 2025-03-31 | $8.1k | 6.6k | 1.22 |
| 2024-12-31 | $9.8k | 7.6k | 1.29 |
| 2024-09-30 | $9.0k | 3.3k | 2.75 |
| 2024-06-30 | $10k | 4.4k | 2.26 |
| 2024-03-31 | $13k | 5.6k | 2.39 |
| 2023-09-30 | $26k | 14k | 1.92 |
| 2023-06-30 | $13k | 8.7k | 1.44 |
| 2023-03-31 | $13k | 6.2k | 2.10 |
| 2022-12-31 | $22k | 12k | 1.78 |
| 2022-09-30 | $14k | 7.4k | 1.95 |
| 2022-06-30 | $9.4k | 7.2k | 1.31 |
| 2022-03-31 | $4.0k | 2.4k | 1.63 |
| 2021-12-31 | $19k | 9.4k | 2.02 |
| 2021-09-30 | $12k | 3.1k | 3.91 |
| 2021-06-30 | $33k | 10k | 3.23 |
| 2021-03-31 | $11k | 5.1k | 2.17 |
| 2020-12-31 | $37k | 17k | 2.22 |
| 2020-09-30 | $114k | 43k | 2.66 |
| 2020-06-30 | $26k | 8.6k | 3.04 |
| 2020-03-31 | $4.0k | 2.1k | 1.87 |
| 2019-09-30 | $4.0k | 978 | 4.09 |
| 2019-06-30 | $17k | 4.0k | 4.22 |
| 2019-03-31 | $39k | 7.6k | 5.14 |
| 2018-09-30 | $51k | 8.4k | 6.05 |
| 2018-06-30 | $7.0k | 1.1k | 6.40 |
| 2016-03-31 | $0 | 60 | 0.00 |
| 2015-12-31 | $15k | 8.9k | 1.69 |
| 2015-09-30 | $998 | 334 | 2.99 |
| 2015-06-30 | $4.1k | 773 | 5.24 |
| 2015-03-31 | $3.0k | 974 | 3.08 |
| 2014-12-31 | $28k | 8.2k | 3.43 |
| 2014-09-30 | $36k | 7.1k | 5.10 |
| 2014-06-30 | $200k | 15k | 13.67 |
| 2014-03-31 | $2.0k | 100 | 20.00 |
| 2013-12-31 | $30k | 3.8k | 7.99 |
| 2013-09-30 | $48k | 4.8k | 9.95 |